Rush Cancer Institute MDS Center — Chicago, Illinois

Rush Cancer Institute MDS Center is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Rush Cancer Institute MDS Center has participated in 1 clinical trials.

Therapeutic areas: Myelodysplastic Syndrome.

Sponsors: Novacea.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Cancer Institute MDS Center?

Rush Cancer Institute MDS Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Cancer Institute MDS Center conducted?

Rush Cancer Institute MDS Center has 1 clinical trials on record. Their work covers Myelodysplastic Syndrome.

Is Rush Cancer Institute MDS Center accredited by Crixeo Health?

Rush Cancer Institute MDS Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush Cancer Institute MDS Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.